{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T01:58:40Z","timestamp":1793066320554,"version":"4.5.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T00:00:00Z","timestamp":1676332800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T00:00:00Z","timestamp":1676332800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"This work was supported by the National Natural Science Foundation of China","award":["No. 82071431"],"award-info":[{"award-number":["No. 82071431"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Increasing evidence suggests that patients with Parkinson's disease (PD) present with peripheral autonomic dysfunction (AutD) that even precedes motor deficits, through which \u03b1-synuclein can spread to the central nervous system. However, the pathological mechanisms underlying AutD in prodromal PD remain unclear. Here, we investigated the role of \u03b1-synuclein and its interplay with the activation of Schwann cells (SCs) of the vagus nerve in AutD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Rats were subjected to injection with adeno-associated viruses containing the human mutated A53T gene (AAV-A53T) or an empty vector into the left cervical vagus nerve and evaluated for gastrointestinal symptoms, locomotor functions, intestinal blood flow, and nerve electrophysiology. Further, we examined the impact of \u03b1-synucleinopathy on vagus nerves, SCs, and central nervous system neurons using electron microscopy, immunofluorescence, immunohistochemistry, and western blot. Finally, the role of Toll-like receptor 2 (TLR2) in regulating the neuroinflammation in the vagus nerve via MyD88 and NF-\u03baB pathway was determined using genetic knockdown.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We found that rats injected with AAV-A53T in the vagus nerve exhibited prominent signs of AutD, preceding the onset of motor deficits and central dopaminergic abnormalities by at least 3\u00a0months, which could serve as a model for prodromal PD. In addition, reduced intestinal blood flow and decreased nerve conduction velocity were identified in AAV-A53T-injected rats, accompanied by disrupted myelin sheaths and swollen SCs in the vagus nerve. Furthermore, our data demonstrated that p-\u03b1-synuclein was deposited in SCs but not in axons, activating the TLR2\/MyD88\/NF-\u03baB signaling pathway and leading to neuroinflammatory responses. In contrast, silencing the TLR2 gene not only reduced inflammatory cytokine expression but also ameliorated vagal demyelination and secondary axonal loss, consequently improving autonomic function in rats.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These observations suggest that overexpression of \u03b1-synuclein in the vagus nerve can induce symptoms of AutD in prodromal PD, and provide support for a deeper understanding of the pathological mechanisms underlying AutD and the emergence of effective therapeutic strategies for PD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12974-023-02720-1","type":"journal-article","created":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T01:14:36Z","timestamp":1676337276000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["\u03b1-Synuclein induces prodromal symptoms of Parkinson\u2019s disease via activating TLR2\/MyD88\/NF-\u03baB pathway in Schwann cells of vagus nerve in a rat model"],"prefix":"10.1186","volume":"20","author":[{"given":"Yue","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongsheng","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinna","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwen","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangxia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kezhong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,14]]},"reference":[{"issue":"9","key":"2720_CR1","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/S1474-4422(19)30195-4","volume":"18","author":"SY Lim","year":"2019","unstructured":"Lim SY, Tan AH, Ahmad-Annuar A, Klein C, Tan LCS, Rosales RL, et al. Parkinson\u2019s disease in the Western Pacific Region. Lancet Neurol. 2019;18(9):865\u201379.","journal-title":"Lancet Neurol"},{"issue":"10291","key":"2720_CR2","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","volume":"397","author":"BR Bloem","year":"2021","unstructured":"Bloem BR, Okun MS, Klein C. Parkinson\u2019s disease. Lancet. 2021;397(10291):2284\u2013303.","journal-title":"Lancet"},{"issue":"2","key":"2720_CR3","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/mds.27602","volume":"34","author":"K Seppi","year":"2019","unstructured":"Seppi K, Ray Chaudhuri K, Coelho M, Fox SH, Katzenschlager R, Perez Lloret S, et al. Update on treatments for nonmotor symptoms of Parkinson\u2019s disease-an evidence-based medicine review. Mov Disord. 2019;34(2):180\u201398.","journal-title":"Mov Disord"},{"issue":"4","key":"2720_CR4","doi-asserted-by":"publisher","DOI":"10.1212\/NXG.0000000000000348","volume":"5","author":"H Iwaki","year":"2019","unstructured":"Iwaki H, Blauwendraat C, Leonard HL, Liu G, Maple-Gr\u00f8dem J, Corvol JC, et al. Genetic risk of Parkinson disease and progression: an analysis of 13 longitudinal cohorts. Neurol Genet. 2019;5(4): e348.","journal-title":"Neurol Genet"},{"issue":"8","key":"2720_CR5","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1001\/jamaneurol.2015.0703","volume":"72","author":"SM Fereshtehnejad","year":"2015","unstructured":"Fereshtehnejad SM, Romenets SR, Anang JB, Latreille V, Gagnon JF, Postuma RB. New clinical subtypes of Parkinson disease and their longitudinal progression: a prospective cohort comparison with other phenotypes. JAMA Neurol. 2015;72(8):863\u201373.","journal-title":"JAMA Neurol"},{"issue":"4","key":"2720_CR6","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1001\/jamaneurol.2018.4377","volume":"76","author":"E De Pablo-Fern\u00e1ndez","year":"2019","unstructured":"De Pablo-Fern\u00e1ndez E, Lees AJ, Holton JL, Warner TT. Prognosis and neuropathologic correlation of clinical subtypes of Parkinson disease. JAMA Neurol. 2019;76(4):470\u20139.","journal-title":"JAMA Neurol"},{"issue":"22","key":"2720_CR7","doi-asserted-by":"publisher","first-page":"e2045","DOI":"10.1212\/WNL.0000000000006576","volume":"91","author":"D B\u00e4ckstr\u00f6m","year":"2018","unstructured":"B\u00e4ckstr\u00f6m D, Gran\u00e5sen G, Domell\u00f6f ME, Linder J, Jakobson Mo S, Riklund K, et al. Early predictors of mortality in parkinsonism and Parkinson disease: a population-based study. Neurology. 2018;91(22):e2045\u201356.","journal-title":"Neurology"},{"issue":"10","key":"2720_CR8","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/S1474-4422(21)00219-2","volume":"20","author":"Y Sharabi","year":"2021","unstructured":"Sharabi Y, Vatine GD, Ashkenazi A. Parkinson\u2019s disease outside the brain: targeting the autonomic nervous system. Lancet Neurol. 2021;20(10):868\u201376.","journal-title":"Lancet Neurol"},{"issue":"7","key":"2720_CR9","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1002\/mds.29037","volume":"37","author":"X Zhou","year":"2022","unstructured":"Zhou X, Liu Z, Zhou X, Xiang Y, Zhou Z, Zhao Y, et al. The Chinese Parkinson\u2019s Disease Registry (CPDR): study design and baseline patient characteristics. Mov Disord. 2022;37(7):1335\u201345.","journal-title":"Mov Disord"},{"issue":"2","key":"2720_CR10","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/s41583-021-00542-9","volume":"23","author":"J Blesa","year":"2022","unstructured":"Blesa J, Foffani G, Dehay B, Bezard E, Obeso JA. Motor and non-motor circuit disturbances in early Parkinson disease: which happens first? Nat Rev Neurosci. 2022;23(2):115\u201328.","journal-title":"Nat Rev Neurosci"},{"issue":"7","key":"2720_CR11","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1136\/jnnp-2015-311680","volume":"87","author":"KL Adams-Carr","year":"2016","unstructured":"Adams-Carr KL, Bestwick JP, Shribman S, Lees A, Schrag A, Noyce AJ. Constipation preceding Parkinson\u2019s disease: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2016;87(7):710\u20136.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"2720_CR12","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/S1474-4422(15)00007-1","volume":"14","author":"A Fasano","year":"2015","unstructured":"Fasano A, Visanji NP, Liu LW, Lang AE, Pfeiffer RF. Gastrointestinal dysfunction in Parkinson\u2019s disease. Lancet Neurol. 2015;14(6):625\u201339.","journal-title":"Lancet Neurol"},{"issue":"6","key":"2720_CR13","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s00401-010-0664-3","volume":"119","author":"TG Beach","year":"2010","unstructured":"Beach TG, Adler CH, Sue LI, Vedders L, Lue L, White Iii CL, et al. Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders. Acta Neuropathol. 2010;119(6):689\u2013702.","journal-title":"Acta Neuropathol"},{"issue":"4","key":"2720_CR14","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s00401-017-1684-z","volume":"133","author":"K Doppler","year":"2017","unstructured":"Doppler K, Jentschke HM, Schulmeyer L, Vadasz D, Janzen A, Luster M, et al. Dermal phospho-alpha-synuclein deposits confirm REM sleep behaviour disorder as prodromal Parkinson\u2019s disease. Acta Neuropathol. 2017;133(4):535\u201345.","journal-title":"Acta Neuropathol"},{"issue":"4","key":"2720_CR15","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.neuron.2019.05.035","volume":"103","author":"S Kim","year":"2019","unstructured":"Kim S, Kwon SH, Kam TI, Panicker N, Karuppagounder SS, Lee S, et al. Transneuronal propagation of pathologic \u03b1-synuclein from the gut to the brain models Parkinson\u2019s disease. Neuron. 2019;103(4):627-41.e7.","journal-title":"Neuron"},{"issue":"2","key":"2720_CR16","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s00401-013-1214-6","volume":"127","author":"D Hilton","year":"2014","unstructured":"Hilton D, Stephens M, Kirk L, Edwards P, Potter R, Zajicek J, et al. Accumulation of \u03b1-synuclein in the bowel of patients in the pre-clinical phase of Parkinson\u2019s disease. Acta Neuropathol. 2014;127(2):235\u201341.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"2720_CR17","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1038\/s41467-019-14189-9","volume":"11","author":"XJ Wang","year":"2020","unstructured":"Wang XJ, Ma MM, Zhou LB, Jiang XY, Hao MM, Teng RKF, et al. Autonomic ganglionic injection of \u03b1-synuclein fibrils as a model of pure autonomic failure \u03b1-synucleinopathy. Nat Commun. 2020;11(1):934.","journal-title":"Nat Commun"},{"key":"2720_CR18","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.parkreldis.2018.10.003","volume":"60","author":"H Zhang","year":"2019","unstructured":"Zhang H, Zhu L, Sun L, Zhi Y, Ding J, Yuan YS, et al. Phosphorylated \u03b1-synuclein deposits in sural nerve deriving from Schwann cells: a biomarker for Parkinson\u2019s disease. Parkinsonism Relat Disord. 2019;60:57\u201363.","journal-title":"Parkinsonism Relat Disord"},{"issue":"5","key":"2720_CR19","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1111\/cns.13282","volume":"26","author":"H Zhang","year":"2020","unstructured":"Zhang H, Wu J, Shen FF, Yuan YS, Li X, Ji P, et al. Activated Schwann cells and increased inflammatory cytokines IL-1\u03b2, IL-6, and TNF-\u03b1 in patients\u2019 sural nerve are lack of tight relationship with specific sensory disturbances in Parkinson\u2019s disease. CNS Neurosci Ther. 2020;26(5):518\u201326.","journal-title":"CNS Neurosci Ther"},{"issue":"1","key":"2720_CR20","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/s41420-021-00676-w","volume":"7","author":"L Sun","year":"2021","unstructured":"Sun L, Jiang WW, Wang Y, Yuan YS, Rong Z, Wu J, et al. Phosphorylated \u03b1-synuclein aggregated in Schwann cells exacerbates peripheral neuroinflammation and nerve dysfunction in Parkinson\u2019s disease through TLR2\/NF-\u03baB pathway. Cell Death Discov. 2021;7(1):289.","journal-title":"Cell Death Discov"},{"issue":"3","key":"2720_CR21","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/mds.27556","volume":"34","author":"DP Breen","year":"2019","unstructured":"Breen DP, Halliday GM, Lang AE. Gut-brain axis and the spread of \u03b1-synuclein pathology: vagal highway or dead end? Mov Disord. 2019;34(3):307\u201316.","journal-title":"Mov Disord"},{"issue":"2","key":"2720_CR22","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, R\u00fcb U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging. 2003;24(2):197\u2013211.","journal-title":"Neurobiol Aging"},{"issue":"21","key":"2720_CR23","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1212\/WNL.0000000000003961","volume":"88","author":"B Liu","year":"2017","unstructured":"Liu B, Fang F, Pedersen NL, Tillander A, Ludvigsson JF, Ekbom A, et al. Vagotomy and Parkinson disease: a Swedish register-based matched-cohort study. Neurology. 2017;88(21):1996\u20132002.","journal-title":"Neurology"},{"issue":"4","key":"2720_CR24","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1002\/ana.24448","volume":"78","author":"E Svensson","year":"2015","unstructured":"Svensson E, Horv\u00e1th-Puh\u00f3 E, Thomsen RW, Djurhuus JC, Pedersen L, Borghammer P, et al. Vagotomy and subsequent risk of Parkinson\u2019s disease. Ann Neurol. 2015;78(4):522\u20139.","journal-title":"Ann Neurol"},{"issue":"1","key":"2720_CR25","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/s41531-021-00190-x","volume":"7","author":"B Mondal","year":"2021","unstructured":"Mondal B, Choudhury S, Banerjee R, Roy A, Chatterjee K, Basu P, et al. Non-invasive vagus nerve stimulation improves clinical and molecular biomarkers of Parkinson\u2019s disease in patients with freezing of gait. NPJ Parkinsons Dis. 2021;7(1):46.","journal-title":"NPJ Parkinsons Dis"},{"issue":"4","key":"2720_CR26","doi-asserted-by":"publisher","first-page":"449","DOI":"10.3233\/NRE-192909","volume":"45","author":"O Kaut","year":"2019","unstructured":"Kaut O, Janocha L, Weism\u00fcller TJ, W\u00fcllner U. Transcutaneous vagal nerve stimulation improves gastroenteric complaints in Parkinson\u2019s disease patients. NeuroRehabilitation. 2019;45(4):449\u201351.","journal-title":"NeuroRehabilitation"},{"issue":"6","key":"2720_CR27","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1002\/mds.27662","volume":"34","author":"B Mondal","year":"2019","unstructured":"Mondal B, Choudhury S, Simon B, Baker MR, Kumar H. Noninvasive vagus nerve stimulation improves gait and reduces freezing of gait in Parkinson\u2019s disease. Mov Disord. 2019;34(6):917\u20138.","journal-title":"Mov Disord"},{"issue":"6","key":"2720_CR28","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.brs.2017.08.008","volume":"10","author":"AQ Farrand","year":"2017","unstructured":"Farrand AQ, Helke KL, Gregory RA, Gooz M, Hinson VK, Boger HA. Vagus nerve stimulation improves locomotion and neuronal populations in a model of Parkinson\u2019s disease. Brain Stimul. 2017;10(6):1045\u201354.","journal-title":"Brain Stimul"},{"issue":"11","key":"2720_CR29","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1007\/s11064-018-2639-z","volume":"43","author":"Y Jiang","year":"2018","unstructured":"Jiang Y, Cao Z, Ma H, Wang G, Wang X, Wang Z, et al. Auricular vagus nerve stimulation exerts antiinflammatory effects and immune regulatory function in a 6-OHDA model of Parkinson\u2019s disease. Neurochem Res. 2018;43(11):2155\u201364.","journal-title":"Neurochem Res"},{"key":"2720_CR30","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abd3994","author":"WH Chiu","year":"2021","unstructured":"Chiu WH, Kovacheva L, Musgrove RE, Arien-Zakay H, Koprich JB, Brotchie JM, et al. \u03b1-Synuclein-induced Kv4 channelopathy in mouse vagal motoneurons drives nonmotor parkinsonian symptoms. Sci Adv. 2021. https:\/\/doi.org\/10.1126\/sciadv.abd3994.","journal-title":"Sci Adv"},{"key":"2720_CR31","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s40035-019-0146-z","volume":"8","author":"L Rota","year":"2019","unstructured":"Rota L, Pellegrini C, Benvenuti L, Antonioli L, Fornai M, Blandizzi C, et al. Constipation, deficit in colon contractions and alpha-synuclein inclusions within the colon precede motor abnormalities and neurodegeneration in the central nervous system in a mouse model of alpha-synucleinopathy. Transl Neurodegener. 2019;8:5.","journal-title":"Transl Neurodegener"},{"key":"2720_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.743708","volume":"13","author":"L Sheng","year":"2022","unstructured":"Sheng L, Hu F, Yu H, Tao X, Jia R, Gu Y, et al. Paeoniflorin inhibits ASK1-TF axis by up-regulating SOCS3 to alleviate radiation enteritis. Front Pharmacol. 2022;13: 743708.","journal-title":"Front Pharmacol"},{"key":"2720_CR33","doi-asserted-by":"publisher","first-page":"6370","DOI":"10.1038\/srep06370","volume":"4","author":"W Boehmerle","year":"2014","unstructured":"Boehmerle W, Huehnchen P, Peruzzaro S, Balkaya M, Endres M. Electrophysiological, behavioral and histological characterization of paclitaxel, cisplatin, vincristine and bortezomib-induced neuropathy in C57Bl\/6 mice. Sci Rep. 2014;4:6370.","journal-title":"Sci Rep"},{"issue":"1","key":"2720_CR34","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41422-019-0241-9","volume":"30","author":"EH Ahn","year":"2020","unstructured":"Ahn EH, Kang SS, Liu X, Chen G, Zhang Z, Chandrasekharan B, et al. Initiation of Parkinson\u2019s disease from gut to brain by \u03b4-secretase. Cell Res. 2020;30(1):70\u201387.","journal-title":"Cell Res"},{"issue":"1","key":"2720_CR35","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/s12974-017-0994-3","volume":"14","author":"Y Liu","year":"2017","unstructured":"Liu Y, Xie X, Xia LP, Lv H, Lou F, Ren Y, et al. Peripheral immune tolerance alleviates the intracranial lipopolysaccharide injection-induced neuroinflammation and protects the dopaminergic neurons from neuroinflammation-related neurotoxicity. J Neuroinflammation. 2017;14(1):223.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"2720_CR36","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s12974-022-02496-w","volume":"19","author":"A Heidari","year":"2022","unstructured":"Heidari A, Yazdanpanah N, Rezaei N. The role of Toll-like receptors and neuroinflammation in Parkinson\u2019s disease. J Neuroinflammation. 2022;19(1):135.","journal-title":"J Neuroinflammation"},{"issue":"10","key":"2720_CR37","doi-asserted-by":"publisher","first-page":"4727","DOI":"10.1172\/JCI99308","volume":"128","author":"DE Allard","year":"2018","unstructured":"Allard DE, Wang Y, Li JJ, Conley B, Xu EW, Sailer D, et al. Schwann cell-derived periostin promotes autoimmune peripheral polyneuropathy via macrophage recruitment. J Clin Invest. 2018;128(10):4727\u201341.","journal-title":"J Clin Invest"},{"issue":"2","key":"2720_CR38","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nrn.2016.178","volume":"18","author":"DJ Surmeier","year":"2017","unstructured":"Surmeier DJ, Obeso JA, Halliday GM. Selective neuronal vulnerability in Parkinson disease. Nat Rev Neurosci. 2017;18(2):101\u201313.","journal-title":"Nat Rev Neurosci"},{"key":"2720_CR39","doi-asserted-by":"publisher","first-page":"455","DOI":"10.3389\/fneur.2018.00455","volume":"9","author":"N Gigu\u00e8re","year":"2018","unstructured":"Gigu\u00e8re N, Burke Nanni S, Trudeau LE. On cell loss and selective vulnerability of neuronal populations in Parkinson\u2019s disease. Front Neurol. 2018;9:455.","journal-title":"Front Neurol"},{"issue":"12","key":"2720_CR40","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1002\/mds.26431","volume":"30","author":"D Berg","year":"2015","unstructured":"Berg D, Postuma RB, Adler CH, Bloem BR, Chan P, Dubois B, et al. MDS research criteria for prodromal Parkinson\u2019s disease. Mov Disord. 2015;30(12):1600\u201311.","journal-title":"Mov Disord"},{"issue":"10","key":"2720_CR41","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1002\/mds.27802","volume":"34","author":"S Heinzel","year":"2019","unstructured":"Heinzel S, Berg D, Gasser T, Chen H, Yao C, Postuma RB. Update of the MDS research criteria for prodromal Parkinson\u2019s disease. Mov Disord. 2019;34(10):1464\u201370.","journal-title":"Mov Disord"},{"issue":"4","key":"2720_CR42","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1002\/mds.27616","volume":"34","author":"A Schrag","year":"2019","unstructured":"Schrag A, Anastasiou Z, Ambler G, Noyce A, Walters K. Predicting diagnosis of Parkinson\u2019s disease: a risk algorithm based on primary care presentations. Mov Disord. 2019;34(4):480\u20136.","journal-title":"Mov Disord"},{"issue":"8","key":"2720_CR43","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1001\/jamaneurol.2017.1125","volume":"74","author":"E De Pablo-Fernandez","year":"2017","unstructured":"De Pablo-Fernandez E, Tur C, Revesz T, Lees AJ, Holton JL, Warner TT. Association of autonomic dysfunction with disease progression and survival in Parkinson disease. JAMA Neurol. 2017;74(8):970\u20136.","journal-title":"JAMA Neurol"},{"issue":"3","key":"2720_CR44","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/s41593-020-0589-7","volume":"23","author":"C Challis","year":"2020","unstructured":"Challis C, Hori A, Sampson TR, Yoo BB, Challis RC, Hamilton AM, et al. Gut-seeded \u03b1-synuclein fibrils promote gut dysfunction and brain pathology specifically in aged mice. Nat Neurosci. 2020;23(3):327\u201336.","journal-title":"Nat Neurosci"},{"issue":"5321","key":"2720_CR45","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"276","author":"MH Polymeropoulos","year":"1997","unstructured":"Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, et al. Mutation in the alpha-synuclein gene identified in families with Parkinson\u2019s disease. Science. 1997;276(5321):2045\u20137.","journal-title":"Science"},{"key":"2720_CR46","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.neuroscience.2019.06.005","volume":"412","author":"P Thakur","year":"2019","unstructured":"Thakur P, Chiu WH, Roeper J, Goldberg JA. \u03b1-Synuclein 2.0\u2014moving towards Cell Type Specific Pathophysiology. Neuroscience. 2019;412:248\u201356.","journal-title":"Neuroscience"},{"issue":"1","key":"2720_CR47","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41531-021-00263-x","volume":"8","author":"C Pellegrini","year":"2022","unstructured":"Pellegrini C, D\u2019Antongiovanni V, Miraglia F, Rota L, Benvenuti L, Di Salvo C, et al. Enteric \u03b1-synuclein impairs intestinal epithelial barrier through caspase-1-inflammasome signaling in Parkinson\u2019s disease before brain pathology. NPJ Parkinsons Dis. 2022;8(1):9.","journal-title":"NPJ Parkinsons Dis"},{"issue":"12","key":"2720_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0028032","volume":"6","author":"CB Forsyth","year":"2011","unstructured":"Forsyth CB, Shannon KM, Kordower JH, Voigt RM, Shaikh M, Jaglin JA, et al. Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson\u2019s disease. PLoS ONE. 2011;6(12): e28032.","journal-title":"PLoS ONE"},{"key":"2720_CR49","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40478-015-0196-0","volume":"3","author":"T Clairembault","year":"2015","unstructured":"Clairembault T, Leclair-Visonneau L, Coron E, Bourreille A, Le Dily S, Vavasseur F, et al. Structural alterations of the intestinal epithelial barrier in Parkinson\u2019s disease. Acta Neuropathol Commun. 2015;3:12.","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"2720_CR50","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","volume":"318","author":"H Braak","year":"2004","unstructured":"Braak H, Ghebremedhin E, R\u00fcb U, Bratzke H, Del Tredici K. Stages in the development of Parkinson\u2019s disease-related pathology. Cell Tissue Res. 2004;318(1):121\u201334.","journal-title":"Cell Tissue Res"},{"issue":"5","key":"2720_CR51","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1093\/jnen\/61.5.413","volume":"61","author":"K Del Tredici","year":"2002","unstructured":"Del Tredici K, R\u00fcb U, De Vos RA, Bohl JR, Braak H. Where does parkinson disease pathology begin in the brain? J Neuropathol Exp Neurol. 2002;61(5):413\u201326.","journal-title":"J Neuropathol Exp Neurol"},{"key":"2720_CR52","doi-asserted-by":"publisher","DOI":"10.1111\/acel.12727","author":"R Rusconi","year":"2018","unstructured":"Rusconi R, Ulusoy A, Aboutalebi H, Di Monte DA. Long-lasting pathological consequences of overexpression-induced \u03b1-synuclein spreading in the rat brain. Aging Cell. 2018. https:\/\/doi.org\/10.1111\/acel.12727.","journal-title":"Aging Cell"},{"issue":"5","key":"2720_CR53","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.3233\/JPD-213053","volume":"12","author":"I Lindberg","year":"2022","unstructured":"Lindberg I, Shu Z, Lam H, Helwig M, Yucer N, Laperle A, et al. The proSAAS chaperone provides neuroprotection and attenuates transsynaptic \u03b1-synuclein spread in rodent models of Parkinson\u2019s disease. J Parkinsons Dis. 2022;12(5):1463\u201378.","journal-title":"J Parkinsons Dis"},{"key":"2720_CR54","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.neubiorev.2020.03.034","volume":"113","author":"P Rosso","year":"2020","unstructured":"Rosso P, Iannitelli A, Pacitti F, Quartini A, Fico E, Fiore M, et al. Vagus nerve stimulation and neurotrophins: a biological psychiatric perspective. Neurosci Biobehav Rev. 2020;113:338\u201353.","journal-title":"Neurosci Biobehav Rev"},{"key":"2720_CR55","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.parkreldis.2018.06.002","volume":"55","author":"K Tsukita","year":"2018","unstructured":"Tsukita K, Taguchi T, Sakamaki-Tsukita H, Tanaka K, Suenaga T. The vagus nerve becomes smaller in patients with Parkinson\u2019s disease: a preliminary cross-sectional study using ultrasonography. Parkinsonism Relat Disord. 2018;55:148\u20139.","journal-title":"Parkinsonism Relat Disord"},{"key":"2720_CR56","doi-asserted-by":"publisher","first-page":"805","DOI":"10.3389\/fneur.2018.00805","volume":"9","author":"U Walter","year":"2018","unstructured":"Walter U, Tsiberidou P, Kersten M, Storch A, L\u00f6hle M. Atrophy of the vagus nerve in Parkinson\u2019s disease revealed by high-resolution ultrasonography. Front Neurol. 2018;9:805.","journal-title":"Front Neurol"},{"key":"2720_CR57","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.681413","volume":"12","author":"J Horsager","year":"2021","unstructured":"Horsager J, Walter U, Fedorova TD, Andersen KB, Skj\u00e6rb\u00e6k C, Knudsen K, et al. Vagus nerve cross-sectional area in patients with Parkinson\u2019s disease\u2014an ultrasound case-control study. Front Neurol. 2021;12: 681413.","journal-title":"Front Neurol"},{"issue":"8","key":"2720_CR58","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1002\/mds.25776","volume":"29","author":"E Gelpi","year":"2014","unstructured":"Gelpi E, Navarro-Otano J, Tolosa E, Gaig C, Compta Y, Rey MJ, et al. Multiple organ involvement by alpha-synuclein pathology in Lewy body disorders. Mov Disord. 2014;29(8):1010\u20138.","journal-title":"Mov Disord"},{"issue":"3","key":"2720_CR59","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1093\/brain\/awaa008","volume":"143","author":"S Mazzetti","year":"2020","unstructured":"Mazzetti S, Basellini MJ, Ferri V, Cassani E, Cereda E, Paolini M, et al. \u03b1-Synuclein oligomers in skin biopsy of idiopathic and monozygotic twin patients with Parkinson\u2019s disease. Brain. 2020;143(3):920\u201331.","journal-title":"Brain"},{"issue":"4","key":"2720_CR60","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1161\/HYPERTENSIONAHA.118.12642","volume":"73","author":"R Isonaka","year":"2019","unstructured":"Isonaka R, Rosenberg AZ, Sullivan P, Corrales A, Holmes C, Sharabi Y, et al. Alpha-synuclein deposition within sympathetic noradrenergic neurons is associated with myocardial noradrenergic deficiency in neurogenic orthostatic hypotension. Hypertension. 2019;73(4):910\u20138.","journal-title":"Hypertension"},{"issue":"14","key":"2720_CR61","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1002\/glia.21041","volume":"58","author":"S Goethals","year":"2010","unstructured":"Goethals S, Ydens E, Timmerman V, Janssens S. Toll-like receptor expression in the peripheral nerve. Glia. 2010;58(14):1701\u20139.","journal-title":"Glia"},{"key":"2720_CR62","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.bbi.2019.06.042","volume":"81","author":"A Kouli","year":"2019","unstructured":"Kouli A, Horne CB, Williams-Gray CH. Toll-like receptors and their therapeutic potential in Parkinson\u2019s disease and \u03b1-synucleinopathies. Brain Behav Immun. 2019;81:41\u201351.","journal-title":"Brain Behav Immun"},{"issue":"4","key":"2720_CR63","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.celrep.2015.09.044","volume":"13","author":"C Kim","year":"2015","unstructured":"Kim C, Rockenstein E, Spencer B, Kim HK, Adame A, Trejo M, et al. Antagonizing neuronal toll-like receptor 2 prevents synucleinopathy by activating autophagy. Cell Rep. 2015;13(4):771\u201382.","journal-title":"Cell Rep"},{"issue":"2","key":"2720_CR64","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s00401-016-1648-8","volume":"133","author":"N Dzamko","year":"2017","unstructured":"Dzamko N, Gysbers A, Perera G, Bahar A, Shankar A, Gao J, et al. Toll-like receptor 2 is increased in neurons in Parkinson\u2019s disease brain and may contribute to alpha-synuclein pathology. Acta Neuropathol. 2017;133(2):303\u201319.","journal-title":"Acta Neuropathol"},{"issue":"376","key":"2720_CR65","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1126\/scisignal.2005965","volume":"8","author":"SG Daniele","year":"2015","unstructured":"Daniele SG, B\u00e9raud D, Davenport C, Cheng K, Yin H, Maguire-Zeiss KA. Activation of MyD88-dependent TLR1\/2 signaling by misfolded \u03b1-synuclein, a protein linked to neurodegenerative disorders. Sci Signal. 2015;8(376):45.","journal-title":"Sci Signal."},{"issue":"1","key":"2720_CR66","doi-asserted-by":"publisher","first-page":"5382","DOI":"10.1038\/s41467-021-25767-1","volume":"12","author":"D Dutta","year":"2021","unstructured":"Dutta D, Jana M, Majumder M, Mondal S, Roy A, Pahan K. Selective targeting of the TLR2\/MyD88\/NF-\u03baB pathway reduces \u03b1-synuclein spreading in vitro and in vivo. Nat Commun. 2021;12(1):5382.","journal-title":"Nat Commun"},{"issue":"12","key":"2720_CR67","doi-asserted-by":"publisher","first-page":"e1672","DOI":"10.1212\/WNL.0000000000011630","volume":"96","author":"X Kang","year":"2021","unstructured":"Kang X, Ploner A, Pedersen NL, Bandres-Ciga S, Noyce AJ, Wirdefeldt K, et al. Tumor necrosis factor inhibition and parkinson disease: a mendelian randomization study. Neurology. 2021;96(12):e1672\u20139.","journal-title":"Neurology"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-023-02720-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12974-023-02720-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-023-02720-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T03:09:31Z","timestamp":1676344171000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-023-02720-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,14]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2720"],"URL":"https:\/\/doi.org\/10.1186\/s12974-023-02720-1","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,14]]},"assertion":[{"value":"30 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were performed in accordance with animal ethics protocols and approved by the Institutional Animal Care and Use Committee of the Nanjing Medical University Experimental Animal Department. This study was approved by the Ethics Committee of the First Affiliated Hospital of Nanjing Medical University. All subjects were fully informed of the aims of the study and provided written informed consent prior to participation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All participants have provided consent for sample collection and subsequent analyses.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"36"}}